Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionFranklin Resources Inc
Latest Disclosed Ownership2,051,948 shares
Latest Disclosed Value $ 469,341,976
Franklin Resources Inc reports 7.43% increase in ownership of ASND / Ascendis Pharma A/S

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 2,051,948 shares of Ascendis Pharma A/S (US:ASND) valued at $469,342,066 USD as of March 31, 2026. The current value of the position is $444,841,807 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 2,051,948 141,869 7.43 469,342 15.23 0.1149
2026-02-11 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,910,079 320,123 20.13 407,305 28.85 0.0999
2025-11-13 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,589,956 -163,512 -9.33 316,099 4.44 0.0788
2025-08-12 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,753,468 113,347 6.91 302,649 18.39 0.0802
2025-05-13 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,640,121 283,704 20.92 255,629 36.89 0.0735
2025-02-12 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,356,417 -103,306 -7.08 186,738 -0.42 0.0519
2024-11-27 2024-09-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,459,723 -625,128 -29.98 187,516 -34.05 0.0527
2024-11-12 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,459,723 -625,128 187,516 0.0090
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 2,084,851 102,982 5.20 284,332 -5.10 0.0874
2024-05-13 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,981,869 917,064 86.13 299,599 123.39 0.0949
2024-02-09 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,064,805 -148,480 -12.24 134,112 18.04 0.0627
2023-11-13 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,213,285 -40 -0.00 113,612 4.92 0.0577
2023-08-11 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,213,325 -132,579 -9.85 108,289 -24.96 0.0515
2023-05-12 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,345,904 -31,618 -2.30 144,308 -14.22 0.0724
2023-02-10 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,377,522 223,430 19.36 168,237 41.17 0.0874
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,154,092 196,055 20.46 119,171 33.81 0.0649
2022-08-11 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 958,037 36,356 3.94 89,059 -17.67 0.0442
2022-05-13 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 921,681 2,268 0.25 108,168 -12.55 0.0432
2022-02-11 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 919,413 89,702 10.81 123,689 -6.47 0.0446
2021-11-12 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 829,711 35,448 4.46 132,247 26.57 0.0498
2021-08-13 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 794,263 61,888 8.45 104,486 10.70 0.0399
2021-05-13 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 732,375 312 0.04 94,388 -22.69 0.0384
2021-02-10 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 732,063 16,630 2.32 122,094 10.59 0.0517
2020-11-12 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 715,433 17,390 2.49 110,405 10.96 0.0535
2020-08-13 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 698,043 -2,117 -0.30 99,499 26.20 0.0513
2020-05-13 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 700,160 -118,582 -14.48 78,845 -30.78 0.0526
2020-03-11 2019-12-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 818,742 -59,492 -6.77 113,904 34.65 0.0598
2020-02-12 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 818,742 -59,492 113,904 14,387.6347
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 878,234 330 0.04 84,592 -16.32 0.0459
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 877,904 -283 -0.03 101,091 -2.20 0.0538
2019-05-15 2019-03-31 13F/A-1 ASCENDIS PHARMA A S SPONSORED ADR 04351P101 878,187 257,589 41.51 103,363 165.84 0.0554
2019-05-14 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 878,187 257,589 103,363
2019-02-12 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 620,598 28,700 4.85 38,881 -7.30 0.0235
2018-11-13 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 591,898 42,800 7.79 41,942 14.83 0.0209
2018-08-14 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 549,098 47,931 9.56 36,526 11.44 0.0187
2018-05-10 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 501,167 501,167 32,777 0.0166
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.